SL THERAPEUTICS, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 730 KRW | 0.00% |
|
-9.77% | +23.94% |
| 2022 | StemLab Inc. announced that it has received KRW 1.5000006 billion in funding | CI |
| 2022 | StemLab Inc. announced that it expects to receive KRW 1.5000006 billion in funding | CI |
Business Summary
Sales per Business
| KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Stem Cell Culture Solution
100.0
%
| - | - | 438 | 100.0 % | - |
Sales per region
| KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
South Korea
100.0
%
| 231 | 100.0 % | 438 | 100.0 % | +89.66% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Donghoon Oh
CEO | Chief Executive Officer | 61 | - |
Jong-Seong Choi
CEO | Chief Executive Officer | 60 | - |
Seung-Kwon Yoo
PSD | President | 59 | - |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Joon Chung
BRD | Director/Board Member | 60 | - |
Jong-Seong Choi
CEO | Chief Executive Officer | 60 | - |
Donghoon Oh
CEO | Chief Executive Officer | 61 | - |
Seung-Kwon Yoo
PSD | President | 59 | - |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 10,378,119 | 2,031,023 ( 19.57 %) | 595,349 ( 5.737 %) | 19.57 % |
Company contact information
Sector
Sales per Business
| 1st Jan change | Capi. | |
|---|---|---|
| +23.94% | 2.79M | |
| -1.62% | 89.22B | |
| +1.32% | 40.49B | |
| -15.79% | 32.79B | |
| +64.13% | 26.23B | |
| -21.38% | 14.52B | |
| -7.97% | 13.09B | |
| -44.07% | 11.6B | |
| -13.06% | 11.5B | |
| +4.94% | 8.82B |
- Stock Market
- Equities
- A258540 Stock
- Company SL Therapeutics, Inc.
